Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides

BACKGROUND: The clinical development of antimicrobial peptides (AMPs) is currently under evaluation to combat the rapid increase in MDR bacterial pathogens. However, many AMPs closely resemble components of the human innate immune system and the ramifications of prolonged bacterial exposure to AMPs...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Antimicrob Chemother
Huvudupphovsmän: Kubicek-Sutherland, Jessica Z., Lofton, Hava, Vestergaard, Martin, Hjort, Karin, Ingmer, Hanne, Andersson, Dan I.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2017
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5161045/
https://ncbi.nlm.nih.gov/pubmed/27650186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw381
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk